Watchlist Manager

Watchlist

Price: 3 770 KRW 0.4% Market Closed

Market Cap: ₩82.8B

	PharmGen Science Inc KRX:004720	KR
A	Aerospace Nanhu Electronic Information Technology Co Ltd SSE:688552	CN
H	Heritage Global Inc NASDAQ:HGBL	US
	Beijing GeoEnviron Engineering & Technology Inc SSE:603588	CN
T	Tokai Holdings Corp TSE:3167	JP
N	Ngai Hing Hong Co Ltd HKEX:1047	HK
C	Central China Securities Co Ltd HKEX:1375	CN

Income Statement

Currency: KRW

	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	1 619	0	0	0	1 432	0	0	0	902	308	0	0	384	191	0	0	860	580	0	0	662	172	0	337	511	428	428	263	124	1	0	0	246	640	1 034	1 442	1 475	1 180	0	417	290	328	0	0	1 721	0	0	0	3 509	0	0	0	4 264	0	0	0	4 157	0	0	0
Revenue	40 066 N/A	35 779 -11%	30 733 -14%	29 606 -4%	27 912 -6%	27 315 -2%	28 325 +4%	29 456 +4%	30 292 +3%	31 874 +5%	35 723 +12%	36 995 +4%	38 971 +5%	40 213 +3%	40 326 +0%	42 039 +4%	44 203 +5%	47 986 +9%	51 294 +7%	54 461 +6%	60 405 +11%	64 736 +7%	67 757 +5%	71 531 +6%	71 546 +0%	71 995 +1%	73 488 +2%	75 417 +3%	79 894 +6%	82 126 +3%	85 412 +4%	87 802 +3%	89 102 +1%	90 923 +2%	94 198 +4%	94 214 +0%	95 138 +1%	94 875 0%	93 163 -2%	94 287 +1%	96 614 +2%	97 663 +1%	99 845 +2%	103 480 +4%	109 866 +6%	126 821 +15%	135 543 +7%	144 550 +7%	150 931 +4%	147 560 -2%	154 305 +5%	159 148 +3%	166 779 +5%	171 687 +3%	173 095 +1%	173 599 +0%	171 287 -1%	171 658 +0%	174 631 +2%	174 484 0%
Gross Profit
Cost of Revenue	(14 656)	(13 405)	(13 169)	(13 068)	(12 628)	(12 653)	(12 626)	(12 932)	(14 002)	(15 075)	(15 964)	(16 412)	(17 018)	(17 662)	(18 387)	(19 418)	(20 323)	(21 872)	(22 810)	(24 796)	(28 048)	(30 417)	(32 354)	(34 402)	(31 569)	(32 440)	(33 425)	(34 042)	(38 642)	(39 416)	(41 060)	(43 132)	(42 900)	(43 487)	(44 789)	(43 513)	(44 738)	(44 539)	(43 091)	(43 491)	(43 015)	(44 022)	(44 530)	(45 618)	(49 063)	(57 765)	(62 430)	(67 134)	(69 629)	(65 016)	(66 029)	(66 826)	(68 909)	(69 376)	(68 732)	(66 298)	(63 253)	(63 166)	(62 198)	(61 863)
Gross Profit	25 410 N/A	22 372 -12%	17 562 -22%	16 536 -6%	15 284 -8%	14 661 -4%	15 699 +7%	16 524 +5%	16 289 -1%	16 800 +3%	19 759 +18%	20 583 +4%	21 953 +7%	22 551 +3%	21 939 -3%	22 621 +3%	23 880 +6%	26 114 +9%	28 484 +9%	29 665 +4%	32 357 +9%	34 319 +6%	35 403 +3%	37 129 +5%	39 977 +8%	39 554 -1%	40 062 +1%	41 375 +3%	41 252 0%	42 712 +4%	44 355 +4%	44 672 +1%	46 202 +3%	47 436 +3%	49 408 +4%	50 700 +3%	50 400 -1%	50 336 0%	50 071 -1%	50 796 +1%	53 599 +6%	53 641 +0%	55 316 +3%	57 861 +5%	60 803 +5%	69 057 +14%	73 113 +6%	77 416 +6%	81 302 +5%	82 544 +2%	88 275 +7%	92 322 +5%	97 869 +6%	102 311 +5%	104 363 +2%	107 300 +3%	108 034 +1%	108 492 +0%	112 433 +4%	112 620 +0%
Operating Income
Operating Expenses	(26 272)	(22 833)	(24 673)	(22 738)	(19 362)	(19 893)	(15 792)	(18 021)	(21 321)	(22 828)	(24 726)	(26 684)	(25 384)	(25 980)	(25 921)	(26 371)	(27 490)	(27 699)	(27 518)	(27 285)	(27 833)	(29 841)	(32 512)	(34 228)	(35 141)	(35 362)	(34 786)	(34 781)	(35 242)	(36 177)	(37 289)	(39 483)	(41 215)	(43 113)	(46 100)	(47 448)	(49 213)	(50 041)	(49 033)	(50 263)	(54 269)	(52 472)	(61 298)	(64 851)	(65 841)	(69 482)	(67 183)	(71 114)	(73 830)	(76 346)	(80 748)	(85 290)	(88 743)	(92 119)	(93 877)	(94 498)	(97 390)	(98 817)	(102 154)	(104 027)
Selling, General & Administrative	(22 949)	(19 875)	(21 653)	(21 702)	(18 692)	(19 935)	(16 117)	(16 098)	(20 637)	(22 383)	(24 281)	(26 239)	(24 699)	(25 677)	(25 458)	(25 732)	(26 789)	(26 959)	(26 753)	(26 515)	(27 051)	(29 067)	(31 746)	(33 404)	(34 240)	(34 356)	(33 689)	(33 643)	(34 010)	(35 123)	(35 993)	(38 086)	(39 678)	(41 449)	(44 459)	(45 685)	(47 290)	(48 687)	(47 578)	(48 143)	(51 913)	(52 152)	(60 318)	(61 973)	(62 176)	(65 344)	(63 296)	(66 874)	(69 241)	(71 939)	(75 342)	(79 042)	(81 954)	(84 778)	(86 880)	(87 701)	(90 631)	(92 020)	(95 043)	(96 840)
Research & Development	(726)	0	0	0	(401)	0	0	0	(409)	(209)	0	0	(423)	(227)	(311)	(422)	(437)	(435)	(469)	(478)	(529)	(544)	(545)	(619)	(694)	(800)	(885)	(908)	(986)	(1 012)	(1 244)	(1 333)	(1 240)	(1 227)	(1 041)	(944)	(886)	(824)	(813)	(910)	(1 115)	(1 410)	(2 050)	(2 201)	(2 270)	(2 639)	(2 314)	(2 542)	(2 886)	(2 641)	(3 759)	(4 535)	(5 118)	(5 594)	(4 946)	(4 632)	(4 402)	(4 370)	(4 647)	(4 677)
Depreciation & Amortization	(248)	0	0	0	(269)	0	0	0	(274)	(134)	0	0	(262)	(76)	(151)	(216)	(263)	(276)	(269)	(266)	(253)	(243)	(234)	(218)	(208)	(211)	(216)	(234)	(245)	(256)	(265)	(277)	(298)	(437)	(601)	(818)	(1 036)	(1 120)	(1 195)	(1 213)	(1 241)	(1 254)	(1 272)	(1 262)	(1 395)	(1 499)	(1 573)	(1 698)	(1 703)	(1 766)	(1 651)	(1 716)	(1 670)	(1 751)	(2 051)	(2 165)	(2 358)	(2 427)	(2 464)	(2 509)
Other Operating Expenses	(2 351)	(2 958)	(3 018)	(1 034)	0	42	325	(1 923)	0	(102)	(445)	(445)	0	0	0	0	0	(29)	(27)	(26)	0	13	13	13	0	5	4	4	0	214	213	213	0	0	0	0	0	590	553	3	0	2 344	2 343	585	0	0	0	0	0	0	4	4	0	4	0	0	0	0	0	0
Operating Income	(862) N/A	(460) +47%	(7 108) -1 445%	(6 199) +13%	(4 079) +34%	(5 230) -28%	(92) +98%	(1 497) -1 527%	(5 031) -236%	(6 028) -20%	(4 967) +18%	(6 100) -23%	(3 431) +44%	(3 429) +0%	(3 982) -16%	(3 750) +6%	(3 610) +4%	(1 585) +56%	966 N/A	2 379 +146%	4 524 +90%	4 477 -1%	2 890 -35%	2 901 +0%	4 835 +67%	4 192 -13%	5 276 +26%	6 593 +25%	6 011 -9%	6 534 +9%	7 065 +8%	5 189 -27%	4 986 -4%	4 324 -13%	3 309 -23%	3 253 -2%	1 187 -64%	295 -75%	1 038 +252%	532 -49%	(670) N/A	1 168 N/A	(5 982) N/A	(6 990) -17%	(5 038) +28%	(425) +92%	5 929 N/A	6 302 +6%	7 472 +19%	6 198 -17%	7 528 +21%	7 032 -7%	9 127 +30%	10 192 +12%	10 486 +3%	12 802 +22%	10 643 -17%	9 675 -9%	10 279 +6%	8 594 -16%
Pre-Tax Income
Interest Income Expense	(1 837)	(1 723)	(2 019)	(2 045)	(6 622)	(4 758)	(4 351)	(4 023)	(191)	(843)	(667)	(528)	(313)	(294)	(331)	(542)	(753)	(945)	(1 021)	(773)	(598)	(351)	(250)	(342)	(229)	(213)	(69)	111	152	272	380	435	(270)	(540)	(941)	(1 344)	(1 007)	(1 200)	(978)	(129)	10 811	41 661	38 036	41 475	47 444	87 952	106 988	102 819	83 480	12 739	3 661	1 271	(141)	(604)	(7 583)	(7 390)	(5 315)	(7 664)	(9 873)	(10 746)
Non-Reccuring Items	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(29)	0	0	0	11	0	0	0	2	0	0	0	214	0	0	0	(493)	(432)	(394)	(326)	650	0	0	2 241	2 288	0	0	0	(1 234)	0	0	0	(1 112)	0	0	0	(340)	0	0	0	(3 938)	0	0	0
Gain/Loss on Disposition of Assets	0	0	0	0	6	0	0	0	22	0	0	0	2	2	0	0	(42)	(43)	0	0	(1)	0	0	2	2	2	2	0	0	0	0	4	4	13	13	16	16	7	0	0	(29)	0	0	0	(11)	0	0	0	3	0	0	0	46	0	0	0	(17)	0	0	0
Total Other Income	0	0	0	0	2 005	858	1 365	1 098	(77)	157	(298)	(26)	(118)	(174)	(249)	(251)	(212)	(129)	(139)	(2 064)	(1 804)	(1 803)	(1 827)	87	(109)	(110)	(100)	(108)	(298)	(319)	(332)	(345)	(334)	(303)	(305)	(276)	(442)	(349)	(304)	(290)	(1 191)	(1 380)	(1 560)	(1 382)	790	(559)	(337)	(369)	117	(1 010)	(1 110)	(1 497)	(244)	(1 092)	(1 136)	(6 155)	(356)	(4 249)	(4 168)	906
Pre-Tax Income	(2 693) N/A	(2 183) +19%	(9 127) -318%	(8 245) +10%	(8 690) -5%	(9 130) -5%	(3 078) +66%	(4 421) -44%	(5 278) -19%	(6 714) -27%	(5 932) +12%	(6 654) -12%	(3 860) +42%	(3 895) -1%	(4 561) -17%	(4 542) +0%	(4 645) -2%	(2 704) +42%	(194) +93%	(458) -136%	2 133 N/A	2 322 +9%	813 -65%	2 647 +226%	4 502 +70%	3 872 -14%	5 109 +32%	6 597 +29%	6 079 -8%	6 487 +7%	7 112 +10%	5 282 -26%	3 893 -26%	3 061 -21%	1 682 -45%	1 323 -21%	404 -69%	(1 248) N/A	(244) +80%	2 353 N/A	11 209 +376%	41 449 +270%	30 494 -26%	33 103 +9%	41 949 +27%	86 967 +107%	112 581 +29%	108 752 -3%	89 960 -17%	17 926 -80%	10 079 -44%	6 806 -32%	8 448 +24%	8 496 +1%	1 767 -79%	(743) N/A	1 017 N/A	(2 238) N/A	(3 762) -68%	(1 247) +67%
Net Income
Tax Provision	(1 281)	(939)	(1 408)	(1 511)	(157)	3	879	1 232	(48)	(48)	(106)	(106)	81	76	173	173	25	32	(65)	(65)	(49)	(70)	(393)	(501)	(1 031)	(1 206)	(1 234)	(1 510)	(1 646)	(1 875)	(1 762)	(1 383)	603	1 017	1 009	996	(168)	(161)	(231)	(215)	(2 085)	(8 864)	(6 424)	(7 737)	(9 535)	(18 934)	(25 075)	(24 140)	(19 902)	(4 345)	(2 330)	(2 036)	(2 361)	(2 288)	(1 212)	(493)	1 773	2 370	6 705	5 824
Income from Continuing Operations	(3 974)	(3 122)	(10 535)	(9 756)	(8 847)	(9 128)	(2 200)	(3 189)	(5 326)	(6 762)	(6 038)	(6 760)	(3 779)	(3 819)	(4 388)	(4 369)	(4 621)	(2 671)	(258)	(522)	2 083	2 253	420	2 146	3 471	2 665	3 874	5 086	4 433	4 611	5 351	3 900	4 496	4 080	2 692	2 320	236	(1 408)	(474)	2 140	9 124	32 587	24 072	25 367	32 414	68 034	87 506	84 612	70 058	13 581	7 748	4 770	6 088	6 209	554	(1 237)	2 790	132	2 943	4 577
Income to Minority Interest	52	52	64	25	23	24	14	11	95	111	106	146	81	52	72	42	37	67	56	63	(16)	(51)	(51)	(58)	(18)	(27)	(64)	(218)	(113)	(101)	(83)	90	(28)	(3)	21	4	66	54	43	63	98	133	149	117	52	17	1	2	1	1	1	1	1	1	1	1	1	(14)	(15)	(15)
Net Income (Common)	(3 922) N/A	(3 069) +22%	(10 517) -243%	(9 777) +7%	(8 824) +10%	(9 104) -3%	(2 140) +76%	(3 133) -46%	(5 232) -67%	(6 652) -27%	(5 932) +11%	(6 614) -11%	(3 699) +44%	(3 767) -2%	(4 316) -15%	(4 327) 0%	(4 584) -6%	(2 604) +43%	(202) +92%	(459) -127%	2 067 N/A	2 202 +7%	369 -83%	2 088 +466%	3 452 +65%	2 639 -24%	3 812 +44%	4 870 +28%	4 320 -11%	4 511 +4%	5 267 +17%	3 989 -24%	4 468 +12%	4 076 -9%	2 713 -33%	2 324 -14%	302 -87%	(1 355) N/A	(432) +68%	2 202 N/A	9 222 +319%	32 720 +255%	24 221 -26%	25 484 +5%	32 466 +27%	68 050 +110%	87 508 +29%	84 614 -3%	70 060 -17%	13 583 -81%	7 750 -43%	4 771 -38%	6 089 +28%	6 210 +2%	556 -91%	(1 235) N/A	2 791 N/A	118 -96%	2 929 +2 387%	4 563 +56%
EPS (Diluted)	-653.66 N/A	-511.5 +22%	-1 502.42 -194%	-1 629.5 -8%	-1 470.66 +10%	-1 517.33 -3%	-356.66 +76%	-522.16 -46%	-747.42 -43%	-831.5 -11%	-847.42 -2%	-826.75 +2%	-462.37 +44%	-470.87 -2%	-539.5 -15%	-540.87 0%	-573 -6%	-325.5 +43%	-22.44 +93%	-51 -127%	229.66 N/A	244.66 +7%	41 -83%	232 +466%	345.2 +49%	263.89 -24%	317.66 +20%	442.72 +39%	392.72 -11%	410.09 +4%	438.91 +7%	332.41 -24%	372.33 +12%	339.66 -9%	226.08 -33%	193.66 -14%	25.16 -87%	-112.91 N/A	-30.85 +73%	169.38 N/A	614.79 +263%	1 915.23 +212%	1 651.96 -14%	1 236.42 -25%	1 745.65 +41%	4 408.8 +153%	5 632.82 +28%	1 579.46 -72%	3 244.84 +105%	861.83 -73%	490.12 -43%	303.61 -38%	292.79 -4%	309.19 +6%	28.57 -91%	-68.2 N/A	128.13 N/A	6.49 -95%	144.11 +2 120%	252.31 +75%

Income Statement Balance Sheet Cash Flow Statement

PharmGen Science Inc
KRX:004720

Income Statement

Earnings Waterfall
PharmGen Science Inc

Income Statement
PharmGen Science Inc

See Also

Company

Help

Tools

Stocks

PharmGen Science Inc KRX:004720

Income Statement

Earnings Waterfall PharmGen Science Inc

Income Statement PharmGen Science Inc

See Also

Company

Help

Tools

Stocks

PharmGen Science Inc
KRX:004720

Earnings Waterfall
PharmGen Science Inc

Income Statement
PharmGen Science Inc